Ultimately, our findings revealed that GAS5 deficiency exerted weaker competitive binding ability to miR-17-3p to stimulate the downregulation of Ang-2, thus arresting IL-1β-induced NPC apoptosis and ECM degradation. This evidence concerns the gene IL1B and nasopharyngeal carcinoma.